Why the Shingles Vaccine is Critical for Seniors
As people age, their immune system weakens, a process known as immune senescence. This makes seniors more susceptible to the varicella-zoster virus reactivating as shingles. The Centers for Disease Control and Prevention (CDC) advises all healthy adults 50 and older to receive the two-dose Shingrix vaccine. The vaccine is crucial for preventing not only the painful rash but also severe and long-term health issues.
Shingrix vs. Zostavax: Why the Change?
Shingrix, approved in 2017, is now the only shingles vaccine available in the U.S., replacing the older Zostavax. Shingrix offers superior effectiveness and longer-lasting protection compared to Zostavax. It is over 90% effective in adults 50 and older and significantly lowers the risk of postherpetic neuralgia (PHN). Shingrix provides strong immunity for at least seven years, while Zostavax's protection faded more quickly.
Significant Health Benefits Beyond Pain Prevention
The shingles vaccine offers important benefits for seniors, protecting against complications that can significantly impact their health and quality of life.
Preventing Postherpetic Neuralgia (PHN)
PHN is the most common complication of shingles, causing nerve pain that can last for months or years. Seniors are at higher risk for PHN, and the vaccine can reduce this risk by about 90%.
Reducing Risk of Eye Complications
Shingles near the eye, called herpes zoster ophthalmicus, can lead to inflammation, vision loss, and scarring. The vaccine helps prevent this by reducing shingles outbreaks.
Protecting Against Stroke and Heart Attack
Studies indicate a link between shingles vaccination and a reduced risk of cardiovascular events, with protection lasting up to eight years. This protective effect is thought to be due to the prevention of inflammation caused by the virus.
Lowering Dementia Risk
Preliminary research suggests the shingles vaccine may also help lower the risk of developing dementia. A study found that vaccinated older adults were less likely to be diagnosed with dementia over a seven-year period.
Comparison of Shingles Vaccines (Shingrix vs. Zostavax)
For a comparison of Shingrix and the discontinued Zostavax, including vaccine type, availability, age recommendations, efficacy, and duration of protection, please refer to {Link: NCOA website https://www.ncoa.org/article/is-there-a-free-shingles-vaccine-for-seniors-heres-what-you-should-know/}.
What to Expect with the Shingrix Vaccine
The Shingrix vaccine is administered as two shots in the upper arm muscle. Side effects are common but usually mild to moderate and temporary, lasting only a few days. These can include soreness, redness, or swelling at the injection site, as well as muscle pain, fatigue, headache, and fever.
Conclusion: The Final Word on Why Seniors Need the Shingles Vaccine
There is strong evidence supporting the importance of shingles vaccination for seniors. It offers highly effective protection against a painful rash and serious long-term complications like PHN. Shingrix provides superior and lasting protection with potential added benefits for heart and brain health. The vaccine is accessible and a crucial step for older adults to maintain their health.
Resources
- Centers for Disease Control and Prevention: https://www.cdc.gov/shingles/vaccines/index.html
- Medicare.gov: https://www.medicare.gov/coverage/shingles-shots